AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Research

FDA to Convene Meeting on HIV Patient-Focused Drug Development and HIV Cure Research

FDAMeeting

The Food and Drug Administration (FDA) wants to talk to people living with HIV (PLWH) and HIV/AIDS advocates. On June 14, under its Patient-Focused Drug Development initiative, FDA will ask PLWH to join an open public discussion about: the impact of HIV on your daily life, experience with currently available therapies to treat HIV, your…

HIV Vaccine Awareness Day Bulletin

HVAD Logo

The implementation of scientifically proven HIV prevention strategies is helping to reduce the number of new infections — the annual HIV infection rate globally fell by 22 percent from 2001 to 2011 — but a great deal more must be done. Significant scale-up of proven HIV prevention strategies coupled with the discovery of new HIV…

May 18th HIV Vaccine Awareness Day (HVAD): A Conversation with Dr. Carl Dieffenbach

HVAD Logo

May 18th is HIV Vaccine Awareness Day (HVAD), led by the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. We spoke to Dr. Carl Dieffenbach at NIH, who had this to say about HIV Vaccine Awareness Day: “[On Vaccine Awareness Day] we can take a moment to acknowledge the…

Statement: NIH Discontinues Immunizations in HIV Vaccine Study

NIAID

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, will stop administering injections in its HVTN 505 clinical trial of an investigational HIV vaccine regimen because an independent data and safety monitoring board (DSMB) found during a scheduled interim review that the vaccine regimen did not prevent HIV infection nor…

New NIH Award Aims to Reduce Asian American Hepatitis B Disparities through Health Information Technology

Ronald Valdiserri

A new grant award by the National Institute on Minority Health and Health Disparities (NIMHD) will support the development of new Health Information Technology (HIT) strategies that increase screening for chronic hepatitis B and reduce the impact of hepatitis B among high-risk Asian American and Pacific Islander (AAPI) populations.  Hepatitis B virus (HBV) infection is…

Conversations from CROI 2013: HRSA’s Dr. Laura Cheever

Cheever CROI 2013

In the final episode in my series of conversations from the 2013 Conference on Retroviruses and Opportunistic Infections (CROI) (held in Atlanta earlier this month), I had the opportunity to talk with Dr. Laura Cheever, HRSA’s Acting Associate Administrator for the HIV/AIDS Bureau. At CROI, she and her colleagues shared a new analysis of the…

Addressing the Needs of Individuals Coinfected with HIV and TB

Ronald Valdiserri

This weekend, we observe World Tuberculosis (TB) Day (Sunday, March 24), a day to remember that the global burden of TB remains enormous, particularly among people with HIV/AIDS, among whom TB is the leading cause of death, worldwide. According to the World Health Organization  (WHO), in 2011, 1.4 million people died from TB, including 430,000…

Conversations from CROI 2013: CDC’s Dr. Jonathan Mermin

Mermin Croi 2013

During the 2013 Conference on Retroviruses and Opportunistic Infections  (CROI) in Atlanta earlier this month, I had the opportunity to sit down with Dr. Jonathan Mermin, Director of CDC’s Division of HIV/AIDS Prevention. We discussed some of the important research findings being shared at the conference and their implications for our efforts to respond effectively…

Page 8 of 21« First...78910...20...Last »